9S01 | pdb_00009s01

PYCR1 in complex with L-tartrate


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.65 Å
  • R-Value Free: 
    0.204 (Depositor), 0.204 (DCC) 
  • R-Value Work: 
    0.182 (Depositor), 0.183 (DCC) 
  • R-Value Observed: 
    0.183 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Crystallographic fragment screening reveals new starting points for PYCR1 inhibitor design.

Ragin-Oh, W.Czerwonka, D.Tran, L.H.Forlani, G.Ruszkowski, M.

(2025) Bioorg Chem 165: 109024-109024

  • DOI: https://doi.org/10.1016/j.bioorg.2025.109024
  • Primary Citation of Related Structures:  
    9RZZ, 9S01, 9S02, 9S04

  • PubMed Abstract: 

    Pyrroline-5-carboxylate (P5C) reductase catalyzes the final step in proline biosynthesis. Human P5C reductase isoform 1 (PYCR1) has emerged as a key metabolic enzyme supporting cancer progression through its roles in redox homeostasis, collagen production, and the proline-P5C cycle. Despite its relevance as a therapeutic target, structural and chemical efforts to inhibit PYCR1 remain limited and have largely focused on proline analogs. Here, we report the first crystallographic fragment screening (XFS) campaign against PYCR1, employing a chemically diverse library of 96 compounds. We solved twelve co-crystal structures, featuring ligands occupying the P5C and NADH binding pockets, including dual-site ligands that span both regions. Among the newly identified moieties, sulfonamide and sulfamate groups emerged as notable isosteric replacements for the carboxylate group in the PYCR1 active site. Aromatic substituents in several compounds revealed a cryptic subpocket near the nicotinamide-binding site. Interestingly, halogen-substituted aromatic rings, often present in known PYCR1 inhibitors, exhibited distinct binding orientations, reflecting the flexibility and diversity of interactions in the binding subpockets. High-resolution structures revealed ligand-induced conformational changes in PYCR1, some involving significant rearrangements. Molecular dynamics simulations indicated that these conformations are accessible in the ligand-free enzyme, underscoring the intrinsic plasticity of PYCR1's active site.


  • Organizational Affiliation
    • Department of Structural Biology of Eukaryotes, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Isoform 3 of Pyrroline-5-carboxylate reductase 1, mitochondrial
A, B, C, D, E
342Homo sapiensMutation(s): 0 
Gene Names: PYCR1
EC: 1.5.1.2
UniProt & NIH Common Fund Data Resources
Find proteins for P32322 (Homo sapiens)
Explore P32322 
Go to UniProtKB:  P32322
PHAROS:  P32322
GTEx:  ENSG00000183010 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP32322
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.65 Å
  • R-Value Free:  0.204 (Depositor), 0.204 (DCC) 
  • R-Value Work:  0.182 (Depositor), 0.183 (DCC) 
  • R-Value Observed: 0.183 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 164.196α = 90
b = 88.109β = 90
c = 116.245γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Polish National Science CentrePoland2021/43/B/NZ7/01611

Revision History  (Full details and data files)

  • Version 1.0: 2025-10-15
    Type: Initial release